nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP2D6—Hydroxyurea—head and neck cancer	0.176	0.19	CbGbCtD
Domperidone—CYP3A7—Docetaxel—head and neck cancer	0.112	0.121	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.112	0.121	CbGbCtD
Domperidone—CYP2C8—Fluorouracil—head and neck cancer	0.106	0.114	CbGbCtD
Domperidone—CYP3A5—Docetaxel—head and neck cancer	0.0839	0.0905	CbGbCtD
Domperidone—CYP1A2—Fluorouracil—head and neck cancer	0.0818	0.0882	CbGbCtD
Domperidone—ABCB1—Vinblastine—head and neck cancer	0.0662	0.0715	CbGbCtD
Domperidone—CYP2D6—Vinblastine—head and neck cancer	0.0624	0.0673	CbGbCtD
Domperidone—ABCB1—Docetaxel—head and neck cancer	0.0546	0.0589	CbGbCtD
Domperidone—CYP3A4—Vinblastine—head and neck cancer	0.0397	0.0428	CbGbCtD
Domperidone—CYP3A4—Docetaxel—head and neck cancer	0.0327	0.0353	CbGbCtD
Domperidone—Sudden death—Fluorouracil—head and neck cancer	0.00278	0.0622	CcSEcCtD
Domperidone—Heartburn—Fluorouracil—head and neck cancer	0.00207	0.0462	CcSEcCtD
Domperidone—Menstruation irregular—Docetaxel—head and neck cancer	0.00185	0.0415	CcSEcCtD
Domperidone—Disorientation—Hydroxyurea—head and neck cancer	0.0016	0.0359	CcSEcCtD
Domperidone—Heartburn—Docetaxel—head and neck cancer	0.00149	0.0334	CcSEcCtD
Domperidone—Dysuria—Hydroxyurea—head and neck cancer	0.00116	0.0259	CcSEcCtD
Domperidone—Disorientation—Fluorouracil—head and neck cancer	0.00115	0.0258	CcSEcCtD
Domperidone—Drowsiness—Hydroxyurea—head and neck cancer	0.00111	0.0247	CcSEcCtD
Domperidone—Stomatitis—Hydroxyurea—head and neck cancer	0.00108	0.0241	CcSEcCtD
Domperidone—Lethargy—Fluorouracil—head and neck cancer	0.00105	0.0236	CcSEcCtD
Domperidone—Irritability—Fluorouracil—head and neck cancer	0.000985	0.022	CcSEcCtD
Domperidone—Hot flush—Docetaxel—head and neck cancer	0.000796	0.0178	CcSEcCtD
Domperidone—Menopausal symptoms—Docetaxel—head and neck cancer	0.00079	0.0177	CcSEcCtD
Domperidone—Stomatitis—Fluorouracil—head and neck cancer	0.000775	0.0173	CcSEcCtD
Domperidone—Conjunctivitis—Fluorouracil—head and neck cancer	0.000773	0.0173	CcSEcCtD
Domperidone—Lethargy—Docetaxel—head and neck cancer	0.00076	0.017	CcSEcCtD
Domperidone—Migraine—Docetaxel—head and neck cancer	0.000733	0.0164	CcSEcCtD
Domperidone—Oedema—Hydroxyurea—head and neck cancer	0.000705	0.0158	CcSEcCtD
Domperidone—Constipation—Vinblastine—head and neck cancer	0.000661	0.0148	CcSEcCtD
Domperidone—Arrhythmia—Fluorouracil—head and neck cancer	0.000638	0.0143	CcSEcCtD
Domperidone—Somnolence—Hydroxyurea—head and neck cancer	0.000627	0.014	CcSEcCtD
Domperidone—Dyspepsia—Hydroxyurea—head and neck cancer	0.00062	0.0139	CcSEcCtD
Domperidone—Abdominal pain—Vinblastine—head and neck cancer	0.000611	0.0137	CcSEcCtD
Domperidone—Constipation—Hydroxyurea—head and neck cancer	0.000603	0.0135	CcSEcCtD
Domperidone—Stomatitis—Docetaxel—head and neck cancer	0.00056	0.0125	CcSEcCtD
Domperidone—Conjunctivitis—Docetaxel—head and neck cancer	0.000558	0.0125	CcSEcCtD
Domperidone—Asthenia—Vinblastine—head and neck cancer	0.000555	0.0124	CcSEcCtD
Domperidone—Diarrhoea—Vinblastine—head and neck cancer	0.000529	0.0118	CcSEcCtD
Domperidone—Dizziness—Vinblastine—head and neck cancer	0.000511	0.0114	CcSEcCtD
Domperidone—Oedema—Fluorouracil—head and neck cancer	0.000507	0.0114	CcSEcCtD
Domperidone—Asthenia—Hydroxyurea—head and neck cancer	0.000506	0.0113	CcSEcCtD
Domperidone—Vomiting—Vinblastine—head and neck cancer	0.000491	0.011	CcSEcCtD
Domperidone—Headache—Vinblastine—head and neck cancer	0.000484	0.0108	CcSEcCtD
Domperidone—Diarrhoea—Hydroxyurea—head and neck cancer	0.000482	0.0108	CcSEcCtD
Domperidone—Hypotension—Fluorouracil—head and neck cancer	0.000474	0.0106	CcSEcCtD
Domperidone—Dizziness—Hydroxyurea—head and neck cancer	0.000466	0.0104	CcSEcCtD
Domperidone—Arrhythmia—Docetaxel—head and neck cancer	0.00046	0.0103	CcSEcCtD
Domperidone—Nausea—Vinblastine—head and neck cancer	0.000459	0.0103	CcSEcCtD
Domperidone—Insomnia—Fluorouracil—head and neck cancer	0.000459	0.0103	CcSEcCtD
Domperidone—Somnolence—Fluorouracil—head and neck cancer	0.000451	0.0101	CcSEcCtD
Domperidone—Vomiting—Hydroxyurea—head and neck cancer	0.000448	0.01	CcSEcCtD
Domperidone—Dyspepsia—Fluorouracil—head and neck cancer	0.000447	0.00999	CcSEcCtD
Domperidone—Rash—Hydroxyurea—head and neck cancer	0.000444	0.00994	CcSEcCtD
Domperidone—Dermatitis—Hydroxyurea—head and neck cancer	0.000444	0.00994	CcSEcCtD
Domperidone—Headache—Hydroxyurea—head and neck cancer	0.000442	0.00988	CcSEcCtD
Domperidone—Muscle spasms—Docetaxel—head and neck cancer	0.000431	0.00965	CcSEcCtD
Domperidone—Nausea—Hydroxyurea—head and neck cancer	0.000419	0.00937	CcSEcCtD
Domperidone—Urticaria—Fluorouracil—head and neck cancer	0.000403	0.00902	CcSEcCtD
Domperidone—Palpitations—Docetaxel—head and neck cancer	0.000397	0.00887	CcSEcCtD
Domperidone—Dry mouth—Docetaxel—head and neck cancer	0.000374	0.00836	CcSEcCtD
Domperidone—Oedema—Docetaxel—head and neck cancer	0.000366	0.00819	CcSEcCtD
Domperidone—Pruritus—Fluorouracil—head and neck cancer	0.000359	0.00803	CcSEcCtD
Domperidone—Diarrhoea—Fluorouracil—head and neck cancer	0.000347	0.00777	CcSEcCtD
Domperidone—Hypotension—Docetaxel—head and neck cancer	0.000342	0.00766	CcSEcCtD
Domperidone—Dizziness—Fluorouracil—head and neck cancer	0.000336	0.00751	CcSEcCtD
Domperidone—Insomnia—Docetaxel—head and neck cancer	0.000331	0.00741	CcSEcCtD
Domperidone—Somnolence—Docetaxel—head and neck cancer	0.000326	0.00728	CcSEcCtD
Domperidone—Vomiting—Fluorouracil—head and neck cancer	0.000323	0.00722	CcSEcCtD
Domperidone—Dyspepsia—Docetaxel—head and neck cancer	0.000322	0.00721	CcSEcCtD
Domperidone—Rash—Fluorouracil—head and neck cancer	0.00032	0.00716	CcSEcCtD
Domperidone—Dermatitis—Fluorouracil—head and neck cancer	0.00032	0.00715	CcSEcCtD
Domperidone—Headache—Fluorouracil—head and neck cancer	0.000318	0.00711	CcSEcCtD
Domperidone—Constipation—Docetaxel—head and neck cancer	0.000313	0.00701	CcSEcCtD
Domperidone—Nausea—Fluorouracil—head and neck cancer	0.000301	0.00674	CcSEcCtD
Domperidone—Abdominal pain—Docetaxel—head and neck cancer	0.000289	0.00648	CcSEcCtD
Domperidone—Asthenia—Docetaxel—head and neck cancer	0.000263	0.00588	CcSEcCtD
Domperidone—Pruritus—Docetaxel—head and neck cancer	0.000259	0.0058	CcSEcCtD
Domperidone—Diarrhoea—Docetaxel—head and neck cancer	0.000251	0.00561	CcSEcCtD
Domperidone—Dizziness—Docetaxel—head and neck cancer	0.000242	0.00542	CcSEcCtD
Domperidone—Vomiting—Docetaxel—head and neck cancer	0.000233	0.00521	CcSEcCtD
Domperidone—Rash—Docetaxel—head and neck cancer	0.000231	0.00517	CcSEcCtD
Domperidone—Dermatitis—Docetaxel—head and neck cancer	0.000231	0.00516	CcSEcCtD
Domperidone—Headache—Docetaxel—head and neck cancer	0.000229	0.00513	CcSEcCtD
Domperidone—Nausea—Docetaxel—head and neck cancer	0.000218	0.00487	CcSEcCtD
Domperidone—DRD2—GPCR ligand binding—KISS1—head and neck cancer	0.000104	0.00365	CbGpPWpGaD
Domperidone—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000103	0.00364	CbGpPWpGaD
Domperidone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.0001	0.00354	CbGpPWpGaD
Domperidone—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.94e-05	0.0035	CbGpPWpGaD
Domperidone—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	9.94e-05	0.0035	CbGpPWpGaD
Domperidone—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.91e-05	0.00349	CbGpPWpGaD
Domperidone—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	9.8e-05	0.00345	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	9.73e-05	0.00343	CbGpPWpGaD
Domperidone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.61e-05	0.00338	CbGpPWpGaD
Domperidone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	9.59e-05	0.00338	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—NAT2—head and neck cancer	9.24e-05	0.00325	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	9.11e-05	0.00321	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	8.86e-05	0.00312	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—UROD—head and neck cancer	8.74e-05	0.00308	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—GRP—head and neck cancer	8.54e-05	0.00301	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—TYMS—head and neck cancer	8.25e-05	0.0029	CbGpPWpGaD
Domperidone—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.14e-05	0.00287	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	8.05e-05	0.00283	CbGpPWpGaD
Domperidone—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	7.8e-05	0.00275	CbGpPWpGaD
Domperidone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.75e-05	0.00273	CbGpPWpGaD
Domperidone—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	7.75e-05	0.00273	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—KISS1—head and neck cancer	7.66e-05	0.0027	CbGpPWpGaD
Domperidone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.65e-05	0.00269	CbGpPWpGaD
Domperidone—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	7.64e-05	0.00269	CbGpPWpGaD
Domperidone—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	7.58e-05	0.00267	CbGpPWpGaD
Domperidone—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	7.47e-05	0.00263	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	7.39e-05	0.0026	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—CASP8—head and neck cancer	7.37e-05	0.00259	CbGpPWpGaD
Domperidone—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	7.35e-05	0.00259	CbGpPWpGaD
Domperidone—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	7.25e-05	0.00255	CbGpPWpGaD
Domperidone—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	7.18e-05	0.00253	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	7.13e-05	0.00251	CbGpPWpGaD
Domperidone—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	7.08e-05	0.00249	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	7.03e-05	0.00248	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—KISS1—head and neck cancer	6.96e-05	0.00245	CbGpPWpGaD
Domperidone—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	6.91e-05	0.00243	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	6.85e-05	0.00241	CbGpPWpGaD
Domperidone—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	6.56e-05	0.00231	CbGpPWpGaD
Domperidone—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	6.47e-05	0.00228	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—UROD—head and neck cancer	6.46e-05	0.00228	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—UROD—head and neck cancer	6.32e-05	0.00222	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—GRP—head and neck cancer	6.31e-05	0.00222	CbGpPWpGaD
Domperidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.29e-05	0.00221	CbGpPWpGaD
Domperidone—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	6.22e-05	0.00219	CbGpPWpGaD
Domperidone—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	6.13e-05	0.00216	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—KISS1—head and neck cancer	5.86e-05	0.00206	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	5.82e-05	0.00205	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—GRP—head and neck cancer	5.73e-05	0.00202	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—IL2—head and neck cancer	5.57e-05	0.00196	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—UROD—head and neck cancer	5.47e-05	0.00193	CbGpPWpGaD
Domperidone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	5.46e-05	0.00192	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	5.39e-05	0.0019	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	5.35e-05	0.00188	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—KISS1—head and neck cancer	5.32e-05	0.00187	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	5.32e-05	0.00187	CbGpPWpGaD
Domperidone—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	5.31e-05	0.00187	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	5.24e-05	0.00184	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—PTEN—head and neck cancer	5.24e-05	0.00184	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	5.24e-05	0.00184	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	5.24e-05	0.00184	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	5.11e-05	0.0018	CbGpPWpGaD
Domperidone—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	5.04e-05	0.00177	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—GRP—head and neck cancer	4.83e-05	0.0017	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—UROD—head and neck cancer	4.77e-05	0.00168	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	4.73e-05	0.00167	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	4.56e-05	0.00161	CbGpPWpGaD
Domperidone—KCNH2—Neuronal System—MAPK1—head and neck cancer	4.55e-05	0.0016	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	4.5e-05	0.00158	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—UROD—head and neck cancer	4.49e-05	0.00158	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—GRP—head and neck cancer	4.38e-05	0.00154	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	4.33e-05	0.00152	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	4.27e-05	0.0015	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.25e-05	0.00149	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	4.21e-05	0.00148	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KISS1—head and neck cancer	4.11e-05	0.00145	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—PTEN—head and neck cancer	4.01e-05	0.00141	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—UROD—head and neck cancer	3.81e-05	0.00134	CbGpPWpGaD
Domperidone—KCNH2—Neuronal System—HRAS—head and neck cancer	3.65e-05	0.00129	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	3.64e-05	0.00128	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—NAT2—head and neck cancer	3.63e-05	0.00128	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—TP53—head and neck cancer	3.57e-05	0.00126	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	3.52e-05	0.00124	CbGpPWpGaD
Domperidone—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	3.49e-05	0.00123	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	3.47e-05	0.00122	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GRP—head and neck cancer	3.38e-05	0.00119	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.34e-05	0.00118	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.29e-05	0.00116	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT6—head and neck cancer	3.29e-05	0.00116	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—DPYD—head and neck cancer	3.18e-05	0.00112	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KISS1—head and neck cancer	3.14e-05	0.00111	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	3.12e-05	0.0011	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—YAP1—head and neck cancer	3.02e-05	0.00106	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.96e-05	0.00104	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.95e-05	0.00104	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—UROD—head and neck cancer	2.94e-05	0.00103	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—YAP1—head and neck cancer	2.91e-05	0.00102	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—TP53—head and neck cancer	2.74e-05	0.000963	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NAT2—head and neck cancer	2.68e-05	0.000945	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.68e-05	0.000943	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NAT2—head and neck cancer	2.62e-05	0.000924	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GRP—head and neck cancer	2.59e-05	0.000912	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.58e-05	0.00091	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT6—head and neck cancer	2.51e-05	0.000885	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.41e-05	0.00085	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.39e-05	0.000841	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—DPYD—head and neck cancer	2.35e-05	0.000829	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.33e-05	0.000822	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—DPYD—head and neck cancer	2.3e-05	0.00081	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NAT2—head and neck cancer	2.27e-05	0.0008	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—YAP1—head and neck cancer	2.23e-05	0.000786	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—YAP1—head and neck cancer	2.22e-05	0.000783	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.21e-05	0.000778	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—YAP1—head and neck cancer	2.18e-05	0.000768	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.1e-05	0.00074	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.1e-05	0.00074	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—DPYD—head and neck cancer	1.99e-05	0.000701	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NAT2—head and neck cancer	1.98e-05	0.000697	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—YAP1—head and neck cancer	1.89e-05	0.000666	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NAT2—head and neck cancer	1.87e-05	0.000657	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.82e-05	0.000642	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—TYMS—head and neck cancer	1.81e-05	0.000638	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.79e-05	0.000631	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.76e-05	0.000621	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—DPYD—head and neck cancer	1.74e-05	0.000611	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GPX1—head and neck cancer	1.72e-05	0.000604	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP1A1—head and neck cancer	1.7e-05	0.000598	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—IL2—head and neck cancer	1.68e-05	0.000592	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.68e-05	0.000591	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.66e-05	0.000585	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—YAP1—head and neck cancer	1.65e-05	0.00058	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—DPYD—head and neck cancer	1.64e-05	0.000576	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NAT2—head and neck cancer	1.58e-05	0.000556	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—YAP1—head and neck cancer	1.55e-05	0.000546	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL2—head and neck cancer	1.53e-05	0.000537	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.49e-05	0.000524	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.42e-05	0.0005	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—DPYD—head and neck cancer	1.39e-05	0.000488	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—TYMS—head and neck cancer	1.34e-05	0.000472	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.33e-05	0.000467	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—YAP1—head and neck cancer	1.31e-05	0.000463	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—TYMS—head and neck cancer	1.31e-05	0.000461	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NOTCH1—head and neck cancer	1.31e-05	0.000461	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.3e-05	0.000456	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—IL2—head and neck cancer	1.29e-05	0.000453	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GPX1—head and neck cancer	1.27e-05	0.000447	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.26e-05	0.000442	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GPX1—head and neck cancer	1.24e-05	0.000437	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.24e-05	0.000436	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.23e-05	0.000432	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—MAPK3—head and neck cancer	1.23e-05	0.000432	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NAT2—head and neck cancer	1.22e-05	0.000429	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2—head and neck cancer	1.17e-05	0.000411	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—MAPK1—head and neck cancer	1.17e-05	0.000411	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EGFR—head and neck cancer	1.17e-05	0.000411	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—TYMS—head and neck cancer	1.14e-05	0.0004	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.12e-05	0.000395	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—PIK3CA—head and neck cancer	1.12e-05	0.000393	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GPX1—head and neck cancer	1.07e-05	0.000378	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—DPYD—head and neck cancer	1.07e-05	0.000377	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.06e-05	0.000375	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—YAP1—head and neck cancer	1.01e-05	0.000357	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PIK3CA—head and neck cancer	1.01e-05	0.000357	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—head and neck cancer	1.01e-05	0.000356	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	1e-05	0.000353	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—TYMS—head and neck cancer	9.89e-06	0.000348	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.88e-06	0.000348	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTM1—head and neck cancer	9.78e-06	0.000344	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	9.39e-06	0.000331	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—HRAS—head and neck cancer	9.37e-06	0.00033	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GPX1—head and neck cancer	9.36e-06	0.00033	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—TYMS—head and neck cancer	9.32e-06	0.000328	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP1A1—head and neck cancer	9.27e-06	0.000326	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTM1—head and neck cancer	9.21e-06	0.000324	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—AKT1—head and neck cancer	9.12e-06	0.000321	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—head and neck cancer	9.02e-06	0.000318	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	8.94e-06	0.000315	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—head and neck cancer	8.93e-06	0.000315	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GPX1—head and neck cancer	8.82e-06	0.000311	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTEN—head and neck cancer	8.81e-06	0.00031	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCND1—head and neck cancer	8.79e-06	0.00031	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.74e-06	0.000308	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	8.73e-06	0.000307	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.62e-06	0.000303	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	8.54e-06	0.000301	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTEN—head and neck cancer	8.48e-06	0.000299	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—AKT1—head and neck cancer	8.28e-06	0.000291	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—TYMS—head and neck cancer	7.9e-06	0.000278	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTM1—head and neck cancer	7.8e-06	0.000275	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	7.75e-06	0.000273	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—head and neck cancer	7.66e-06	0.00027	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT3—head and neck cancer	7.59e-06	0.000267	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GPX1—head and neck cancer	7.47e-06	0.000263	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—head and neck cancer	7.47e-06	0.000263	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP1A1—head and neck cancer	7.4e-06	0.00026	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—head and neck cancer	7.3e-06	0.000257	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK3—head and neck cancer	7.25e-06	0.000255	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—HRAS—head and neck cancer	7.17e-06	0.000253	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	6.98e-06	0.000246	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—head and neck cancer	6.9e-06	0.000243	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK1—head and neck cancer	6.9e-06	0.000243	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—head and neck cancer	6.9e-06	0.000243	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCND1—head and neck cancer	6.73e-06	0.000237	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTEN—head and neck cancer	6.52e-06	0.000229	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTEN—head and neck cancer	6.49e-06	0.000229	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTEN—head and neck cancer	6.37e-06	0.000224	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT1—head and neck cancer	6.33e-06	0.000223	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—head and neck cancer	6.33e-06	0.000223	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CA—head and neck cancer	6.22e-06	0.000219	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—TYMS—head and neck cancer	6.09e-06	0.000215	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.08e-06	0.000214	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTM1—head and neck cancer	6.02e-06	0.000212	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CA—head and neck cancer	5.99e-06	0.000211	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—head and neck cancer	5.86e-06	0.000206	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT3—head and neck cancer	5.81e-06	0.000204	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—head and neck cancer	5.79e-06	0.000204	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GPX1—head and neck cancer	5.77e-06	0.000203	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	5.71e-06	0.000201	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK3—head and neck cancer	5.55e-06	0.000195	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HRAS—head and neck cancer	5.54e-06	0.000195	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTEN—head and neck cancer	5.52e-06	0.000194	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—head and neck cancer	5.51e-06	0.000194	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK1—head and neck cancer	5.28e-06	0.000186	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—head and neck cancer	5.28e-06	0.000186	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—head and neck cancer	5.19e-06	0.000183	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—AKT1—head and neck cancer	5.08e-06	0.000179	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT1—head and neck cancer	4.89e-06	0.000172	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTEN—head and neck cancer	4.81e-06	0.000169	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CA—head and neck cancer	4.6e-06	0.000162	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	4.58e-06	0.000161	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTEN—head and neck cancer	4.53e-06	0.000159	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CA—head and neck cancer	4.49e-06	0.000158	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—head and neck cancer	4.43e-06	0.000156	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—head and neck cancer	4.4e-06	0.000155	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HRAS—head and neck cancer	4.24e-06	0.000149	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CA—head and neck cancer	3.89e-06	0.000137	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTEN—head and neck cancer	3.84e-06	0.000135	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKT1—head and neck cancer	3.76e-06	0.000132	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT1—head and neck cancer	3.74e-06	0.000132	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKT1—head and neck cancer	3.67e-06	0.000129	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.4e-06	0.00012	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CA—head and neck cancer	3.39e-06	0.000119	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.2e-06	0.000113	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKT1—head and neck cancer	3.18e-06	0.000112	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTEN—head and neck cancer	2.96e-06	0.000104	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKT1—head and neck cancer	2.77e-06	9.75e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CA—head and neck cancer	2.71e-06	9.53e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKT1—head and neck cancer	2.61e-06	9.19e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKT1—head and neck cancer	2.21e-06	7.79e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.09e-06	7.36e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKT1—head and neck cancer	1.71e-06	6.01e-05	CbGpPWpGaD
